The Cigna Group CI
The Cigna Group is a health insurance and health services provider operating primarily in the United States, offering medical insurance plans, pharmacy benefit management, and healthcare services through its Evernorth and Cigna Healthcare segments. Cigna trades at a P/E of 11.25 and an FCF yield of 11.1%, reflecting an attractive valuation backed by 10.2% earnings growth and a 16.76% ROE, although its 3.98% operating margin is thin and momentum is negative.
Detailed metrics
Market and fundamental data as of the analysis date.
Full AI report
Generated automatically from the metrics, the macro context and the company's news.
The Cigna Group is a health insurance and health services provider operating primarily in the United States, offering medical insurance plans, pharmacy benefit management, and healthcare services through its Evernorth and Cigna Healthcare segments. Cigna trades at a P/E of 11.25 and an FCF yield of 11.1%, reflecting an attractive valuation backed by 10.2% earnings growth and a 16.76% ROE, although its 3.98% operating margin is thin and momentum is negative.
Score by category
| Category | Score |
|---|---|
| Financial health | 4.6 |
| Quality / Moat | 5.4 |
| Valuation | 8.5 |
| Growth | 6.1 |
| Dividend | 6.3 |
| Momentum | 3.0 |
| Risk & Context | 8.3 |
OVERALL SCORE: 6.3/10
Context and risks
Moderate regulatory risk in the US for health insurers: pressure on premium pricing and review of pharmacy benefit management (PBM) practices. Cigna, with its Evernorth segment, is exposed to active regulatory scrutiny that could affect margins.
News considered in the analysis
- What Should CVS Stock Investors Be Watching Now? — Artículo genérico sobre CVS, sin información nueva sobre Cigna.
- 2 Profitable Stocks with Solid Fundamentals and 1 We Avoid — Listículo sin datos específicos de Cigna.
- Liberty HealthShare’s Dorsey Morrow Makes the Financial Case for Healthsharing on Becker’s Healthcare Podcast — Promoción de un competidor de healthsharing, sin impacto directo en Cigna.
- Did UnitedHealth Name The Fix Before Its Stock Ran? — Análisis de UnitedHealth, competidor, sin implicaciones directas para Cigna.
- Can UNH Stock Keep Growing Earnings While Its Sales Stall? — Artículo sobre UnitedHealth, sin información relevante para Cigna.
Verdict: Hold or buy on dips: cheap valuation and stable growth offset regulatory risk and tight margins.
Main risk: The biggest risk is US regulatory pressure on PBMs and healthcare pricing, which could compress the already thin 3.98% operating margin.
Other Healthcare companies
Neighbours in the sector ranking, to compare without going back to the index.
See all 1,000+ companies in the index →